← Leaderboards
Stephanie Siegmund
Columbia University Health Sciences
$187,863
Attributed
$187,863
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $49.5K · FY2015–18$50K$37.5K$25K$12.5K$0
'15
'16
'17
'18
Funding mix
By agency
NIH$187,863 · 1
By mechanism
F30$187,863 · 1
Top collaborators
No co-investigators on record.
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Michio Hirano$20,704,569
- Eric A. Schon$10,877,403
- Salvatore Dimauro$5,976,336
- Eduardo Bonilla$2,069,157
- Chia-Wei Cheng$908,395
Others in their field
Top investigators on “Heterogeneity”
- Chanza Baytop · Westat, Inc.$271,217,917
- Richard A Gibbs · Baylor College Of Medicine$189,765,274
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$171,224,107
- James Dennis Neaton · Northwestern University$166,150,536
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Mary L. Disis · University Of Washington$91,659,868
Research focus
HeterogeneityGlucoseGenus HippocampusAnimal ModelAutophagocytosisCell RespirationBaseGeneticBioenergeticsCoupledDefectCell ModelDna Sequence AlterationEarly InterventionEarly TreatmentCellsClinical TrialsExhibitsFda ApprovedFibroblastsFollow-UpFunctional DisorderGenesHigh Prevalence
Grant awards (4)
Pharmacologic Treatment of Human Mitochondrial DNA (mtDNA) Disease$49,524
F30 · FY2018 · NS · contact PI
Pharmacologic Treatment of Human Mitochondrial DNA (mtDNA) Disease$49,044
F30 · FY2017 · NS · contact PI
Pharmacologic Treatment of Human Mitochondrial DNA (mtDNA) Disease$45,047
F30 · FY2016 · NS · contact PI
Pharmacologic Treatment of Human Mitochondrial DNA (mtDNA) Disease$44,248
F30 · FY2015 · NS · contact PI